Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Sakon

Showing results (211-220 of 216) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 216 results.
Clinical Nutrition ESPEN|August 28, 2019
The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic cancer: Prospective randomized control studyHirofumi Akita, Hidenori Takahashi, Kei Asukai, et al.
Surgery|August 28, 2018
Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse-transcription polymerase chain reaction identifies patients at high risk for peritoneal recurrence and consequent impaired survival in the setting of preoperative chemoradiation therapy for pancreatic cancerHidenori Takahashi, Hirofumi Akita, Hiroshi Wada, et al.
Cancer Science|July 13, 2004
Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinomaYusuke Oji, Shoji Nakamori, Masahiro Fujikawa, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 13, 2019
Feasibility and Safety of a Novel Laparoscopic and Endoscopic Cooperative Surgery Technique for Superficial Duodenal Tumor Resection: How I Do ItYoshitomo Yanagimoto, Takeshi Omori, Moon Jeong-Ho, et al.
BMC Cancer|January 18, 2023
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancerShinichiro Hasegawa, Hidenori Takahashi, Hirofumi Akita, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 9, 2020
Decreased CT-number in the pancreatic parenchyma is a reliable imaging biomarker of the presence of malignancies in patients with high-risk intraductal papillary mucinous neoplasmTomoki Abe, Daisaku Yamada, Kei Asukai, et al.
Pageof 22

Showing results (211-220 of 216) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 216 results.
Clinical Nutrition ESPEN|August 28, 2019
The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic cancer: Prospective randomized control studyHirofumi Akita, Hidenori Takahashi, Kei Asukai, et al.
Surgery|August 28, 2018
Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse-transcription polymerase chain reaction identifies patients at high risk for peritoneal recurrence and consequent impaired survival in the setting of preoperative chemoradiation therapy for pancreatic cancerHidenori Takahashi, Hirofumi Akita, Hiroshi Wada, et al.
Cancer Science|July 13, 2004
Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinomaYusuke Oji, Shoji Nakamori, Masahiro Fujikawa, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 13, 2019
Feasibility and Safety of a Novel Laparoscopic and Endoscopic Cooperative Surgery Technique for Superficial Duodenal Tumor Resection: How I Do ItYoshitomo Yanagimoto, Takeshi Omori, Moon Jeong-Ho, et al.
BMC Cancer|January 18, 2023
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancerShinichiro Hasegawa, Hidenori Takahashi, Hirofumi Akita, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 9, 2020
Decreased CT-number in the pancreatic parenchyma is a reliable imaging biomarker of the presence of malignancies in patients with high-risk intraductal papillary mucinous neoplasmTomoki Abe, Daisaku Yamada, Kei Asukai, et al.
Pageof 22